The closing of this large, structured capital solution demonstrates Apollo's ability to execute complex, multi-billion-euro transactions with blue-chip counterparties, reinforcing its High Grade Capital Solutions growth narrative. Monitor for future similar deals and the pace of Apollo's $100 billion Germany deployment commitment.
How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 16 $124.53entry
- T+1 · 2mo ago +1.18%α +0.05% · $126.00
- T+5 · 8w ago −0.14%α −2.70% · $124.36
- T+20 · 5w ago −6.62%α −9.80% · $116.28
- T+43 · todayOpen
- T+60 · in 23d Pending
Price Chart
How similar events traded
Executive Summary
Apollo-managed funds closed a €3 billion capital solution for Bayer's long-acting reversible contraceptives (LARC) business, with KKR as a minority participant. Apollo retains a leadership role in structuring the deal, which aligns with its strategy of providing large-scale capital solutions to blue-chip companies and its commitment to deploy over $100 billion in Germany over the next decade.
Key Financial Metrics
Key Facts
- Apollo-managed funds closed a €3 billion capital solution for Bayer's LARC business, previously announced on July 10, 2026.
- KKR joined as a significant minority participant in the investment.
- Bayer retains a majority stake and full operational control of the LARC business.
- Apollo committed to deploying more than $100 billion in Germany over the coming decade.
- Apollo had approximately $1.05 trillion in AUM as of June 30, 2026.
Financial Impact
€3 billion capital solution for Bayer's LARC business; Apollo's AUM $1.05 trillion
Risk Factors
- Execution risk on the $100 billion Germany deployment commitment
- Potential regulatory or political scrutiny of large private capital investments in strategic German assets
- LARC business performance may affect returns on the investment
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3362850 |
Track record
32 reports on APO
5 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +22.04% at T+60 after the Feb 28, 2026 report. 7 of 9 went positive at some point.
Filters
- Nov 13, 20263d ago 8-K Neutral 4/10 Entry $122.37 Now $119.98 −1.95% settles Nov 23
- Nov 12, 20264d ago 8-K Neutral 2/10 Entry $121.35 Now $119.98 −1.13% settles Nov 19
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $117.27 to $121.35 Now $119.98 +2.31% ▲ +3.48% +0.19% vs SPY
- Nov 4, 202612d ago 144 Neutral 1/10 Entry $122.76 to $122.95 Now $119.98 −2.26% ▲ +0.15% +1.07% vs SPY
- Nov 3, 202613d ago 8-K Mixed 5/10 No price data
- Nov 3, 202613d ago Press Release Neutral 4/10 Entry $113.55 to $122.74 Now $119.98 +5.66% ▲ +8.09% +8.68% vs SPY
- Oct 30, 202617d ago 8-K Neutral 2/10 Entry $115.84 to $116.75 Now $119.98 +3.57% ▲ +0.79% +3.49% vs SPY
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $113.45 to $122.76 Now $119.98 +5.76% ▲ +8.21% +8.92% vs SPY
- Oct 20, 202627d ago 8-K Neutral 2/10 Entry $111.69 to $114.26 Now $119.98 +7.42% ▲ +2.30% +2.74% vs SPY
- Oct 16, 20264w ago Institutional Cluster Bearish 4/10 Entry $110.95 to $115.24 Now $119.98 −8.14% ▼ −3.87% −4.01% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers